CME on ReachMD-logo

CME on ReachMD

ReachMD

Providing Medical Knowledge on Demand. Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD on your computer at ReachMD.com or download and use the ReachMD MedicalRadio iPhone app and earn CME credit at your convenience.

Providing Medical Knowledge on Demand. Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD on your computer at ReachMD.com or download and use the ReachMD MedicalRadio iPhone app and earn CME credit at your convenience.
More Information

Location:

Fort Washington, PA

Networks:

ReachMD

Description:

Providing Medical Knowledge on Demand. Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD on your computer at ReachMD.com or download and use the ReachMD MedicalRadio iPhone app and earn CME credit at your convenience.

Language:

English


Episodes

Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate

8/13/2018
More
CME credits: 0.50 Valid until: 13-08-2019 Claim your CME credit at https://reachmd.com/programs/cme/clostridium-difficile-infection-applying-new-treatment-guidelines-strategies-reduce-recurrence-rate/10339/ Clostridium difficile infection (CDI) is the leading cause of infectious nosocomial diarrhea in developed countries. Approximately 25% of patients treated for this opportunistic infection experience recurrent or recalcitrant disease, and up to 40% of those patients develop an...

Duration:00:27:59

Raising Expectations for Rosacea: Best Practices That Drive Clear Results

8/10/2018
More
CME credits: 0.50 Valid until: 10-08-2019 Claim your CME credit at https://reachmd.com/programs/cme/raising-expectations-rosacea-best-practices-drive-clear-results/10340/ After encountering rosacea in clinical practice on a regular basis, it can become a force of habit to focus only on the cutaneous manifestations of the disease; however, the pathophysiological changes and comorbidities that make management much more complex are often overlooked. In this activity, Dr. J. Mark Jackson will...

Duration:00:20:59

What is the Role for TKIs in RCC? Highlights from the 18th Annual Meeting of the SUO

8/2/2018
More
CME credits: 0.75 Valid until: 02-08-2019 Claim your CME credit at https://reachmd.com/cme/project-oncology-cme/what-is-the-role-for-tkis-in-rcc-highlights-from-the-18th-annual-meeting-of-the-suo/9994/ Jointly provided by and Although renal cell carcinoma (RCC) accounts for only 2% to 3% of all adult cancers, for those who present with or progress to advanced RCC, the 5-year survival rate has never been above 10%. Several tyrosine-kinase inhibitors (TKIs), along with many other therapies,...

Duration:00:29:59

Multiple Sclerosis in Pediatric & Pregnant Patients: Challenges in Treatment

7/31/2018
More
CME credits: 0.25 Valid until: 31-07-2019 Claim your CME credit at https://reachmd.com/programs/cme/multiple-sclerosis-pediatric-pregnant-patients-challenges-treatment/10334/ MS is a challenging chronic disease to manage for any healthcare professional, but the most difficult cases we often face involve children and pregnant women. Up to 5% of people diagnosed with MS are under the age of 16. The peak age of diagnosis for women falls between 20 and 50 years old; however, that also happens...

Duration:00:13:59

Advances in Preterm Birth Prevention: Subcutaneous vs. Intramuscular Dosing of 17-OHPC – Pharmacokinetic Profile, Patient and Practitioner Impact

7/31/2018
More
CME credits: 0.25 Valid until: 31-07-2019 Claim your CME credit at https://reachmd.com/programs/cme/advances-preterm-birth-prevention-subcutaneous-intramuscular-dosing-17-ohpc/10319/ In light of the availability of a subcutaneously administered 17-OHPC, this activity will discuss strategies for providing optimal clinical management to women at risk for PTB, based on the SMFM, ACOG, and ACNM recommendations. In addition, it will provide information surrounding the pharmacokinetic...

Duration:00:15:00

Role of Fetal Fibronectin (fFN) in the Risk-Assessment for Preterm Birth (PTB)

7/30/2018
More
CME credits: 0.25 Valid until: 30-07-2019 Claim your CME credit at https://reachmd.com/programs/cme/role-fetal-fibronectin-ffn-risk-assessment-preterm-birth-ptb/10258/ About 30% of preterm labor spontaneously resolves and 50% of patients hospitalized for preterm labor actually give birth at term. Clinicians are left with the task to effectively assess women who are at risk for prenatal delivery in order to prevent preterm labor and reduce perinatal morbidity and mortality. In this...

Duration:00:12:59

Oncology On-Que: Expert Answers to Common Questions for Optimizing Platinum-Refractory NSCLC Treatment

7/24/2018
More
CME credits: 0.50 Valid until: 23-07-2019 Claim your CME credit at https://reachmd.com/programs/cme/oncology-on-que-expert-answers-common-questions-for-optimizing-platinum-refractory-nsclc-treatment/10172/ Despite the importance of genomic profiling and the advent of targeted therapies, chemotherapeutic strategies remain a cornerstone treatment for patients with advanced non–small cell lung cancer (NSCLC). This includes those patients without actionable mutations in the treatment-naive...

Duration:00:21:00

Hemophilia Patient Cases: Managing the Challenges of Inhibitors

7/18/2018
More
CME credits: 0.50 Valid until: 18-07-2019 Claim your CME credit at https://reachmd.com/programs/cme/hemophilia-patient-cases-managing-the-challenges-of-inhibitors/10173/ Hemophilia patients that develop inhibitors to factor replacement therapy are not only at increased risk for morbidity and mortality, they pose substantial challenges for treatment and management paradigms. The treatment of hemophilia patients with inhibitors with bypassing agents can be unpredictable. During “Hemophilia...

Duration:00:23:59

The Impact of Cancer on the Young Adult Patient

7/18/2018
More
CME credits: 0.25 Valid until: 18-07-2019 Claim your CME credit at https://reachmd.com/programs/cme/the-impact-of-cancer-on-the-young-adult-patient/9889/ In this segment, Dr. Rokitka describes the Adolescent and Young Adult (AYA) cancer population including what makes them unique and why they need special attention. Also discussed will be the more common cancer types seen among AYAs and what action(s) to take if a malignancy is suspected in an AYA patient. This activity is part of a...

Duration:00:07:59

Challenging Case Studies: Percutaneous Coronary Interventions and Post-discharge Antithrombotic Management

6/29/2018
More
CME credits: 0.25 Valid until: 29-06-2019 Claim your CME credit at https://reachmd.com/programs/cme/challenging-case-studies-percutaneous-coronary-interventions-and-post-discharge-antithrombotic-manag/10181/ Based on a live symposium held on April 26, 2018, this innovative, 15-minute, case-based CME activity features two prominent faculty covering important, timely clinical issues and recent data related to anticoagulation in patients after percutaneous coronary interventions.

Duration:00:14:00

Blunt Tip Cannulas with Hyaluronic Acid Injections in the Face and Lip: Applying Theory in Practice​

6/29/2018
More
CME credits: 0.75 Valid until: 29-06-2019 Claim your CME credit at https://reachmd.com/programs/cme/blunt-tip-cannulas-hyaluronic-acid-injections-in-the-face-and-lip-applying-theory-in-practice/10171/ The blunt-tip cannula provides experienced aesthetic practitioners with an alternative to traditional needle injections for dermal fillers. This educational video will discuss and demonstrate the opportunity that the blunt-tip cannula presents to cover a greater area, with reduced risk for...

Duration:00:14:29

Advances in Immuno-Oncology: Evaluating a Bispecific, Bifunctional Fusion Protein

6/29/2018
More
CME credits: 0.25 Valid until: 29-06-2019 Claim your CME credit at https://reachmd.com/programs/cme/advances-in-immuno-oncology-evaluating-a-bispecific-bifunctional-fusion-protein/10164/ About 20% of patients treated with anti-PD-1/PD-L1 checkpoint inhibitors respond to therapy. At issue is the existence and action of immunosuppressive cytokine transforming growth factor-beta (TGF-β) in the tumor microenvironment, which inhibits the normal anti-tumor action of natural killer cells and T...

Duration:00:13:59

Changing Course: Anticoagulation in Secondary Prevention of Cardiovascular Disease Events

6/26/2018
More
CME credits: 0.25 Valid until: 26-06-2019 Claim your CME credit at https://reachmd.com/programs/cme/changing-course-anticoagulation-secondary-prevention-cardiovascular-disease-events/10180/ This CME activity is based on a live symposium held on April 26, 2018. It features a 15-minute Video Expert Dialogue with two internationally renowned faculty evaluating clinical issues and recent data regarding anticoagulation in patients with coronary artery disease (CAD).

Duration:00:15:30

Complex Vaginitis Cases: Applying New Diagnostic Methods to Enhance Patient Outcomes

6/5/2018
More
CME credits: 0.25 Valid until: 05-06-2019 Claim your CME credit at https://reachmd.com/programs/cme/complex-vaginitis-cases-applying-new-diagnostic-methods-to-enhance-patient-outcomes/10156/ Up to 40% of women who suffer from symptoms of vaginitis cannot be diagnosed at the initial office visit, and 25% are placed on a pharmacologic therapy not based on validated diagnostic testing. “Complex Vaginitis Cases: Applying New Diagnostic Methods to Enhance Patient Outcomes” is a case based,...

Duration:00:11:29

Strategies for Improving Outcomes in Patients with Parkinson’s Disease

6/4/2018
More
CME credits: 0.50 Valid until: 04-06-2019 Claim your CME credit at https://reachmd.com/programs/cme/strategies-improving-outcomes-patients-parkinsons-disease/10157/ Parkinson’s disease (PD) affects roughly one million Americans and more than 10 million people worldwide. It is a progressive neurologic disorder characterized by motor and nonmotor symptoms. Key motor symptoms include resting tremor, bradykinesia, rigidity, and postural instability. Nonmotor symptoms include psychosis,...

Duration:00:31:29

Clinical Debates in Multiple Myeloma: Putting Evidence Into Context

5/23/2018
More
CME credits: 1.00 Valid until: 22-05-2019 Claim your CME credit at https://reachmd.com/programs/cme/clinical-debates-multiple-myeloma-putting-evidence-context/10130/ The treatment armamentarium for multiple myeloma (MM) has expanded significantly in recent years, with 6 new agents or indications approved by the US Food & Drug Administration since 2015. Treatment options now include immunomodulatory drugs, proteasome inhibitors, a histone deacetylase inhibitor, and immunotherapies,...

Duration:00:40:00

Beneath the Surface: Psoriatic Arthritis in Dermatology Practice

5/21/2018
More
CME credits: 0.50 Valid until: 21-05-2019 Claim your CME credit at https://reachmd.com/cme/dermatology/beneath-surface-psoriatic-arthritis-dermatology-practice/10134/ Untreated psoriatic arthritis leads to irreversible joint damage. However, most people with psoriatic arthritis experience multiple symptoms over a period of years before they are properly diagnosed. Dermatology providers are at the front lines, making a psoriatic arthritis diagnosis and helping to prevent joint...

Duration:00:24:29

Immunocellular Therapies for Relapsed/Refractory Heme Malignancies: A Focus on CAR T-Cell Therapy

5/15/2018
More
CME credits: 0.25 Valid until: 14-05-2019 Claim your CME credit at https://reachmd.com/programs/cme/immunocellular-therapies-relapsedrefractory-heme-malignancies-focus-car-t-cell-therapy/10113/ The treatment of relapsed or refractory leukemias and lymphomas continues to be challenging, often characterized by limited therapeutic options and poor outcomes. Effective new therapies are needed for these patients. Chimeric antigen receptor (CAR) T-cell therapy represents a radical departure...

Duration:00:15:00

Innovations in Lung Cancer Diagnosis and Surgical Treatment

5/9/2018
More
CME credits: 0.25 Valid until: 09-05-2019 Claim your CME credit at https://reachmd.com/programs/cme/innovations-in-lung-cancer-diagnosis-and-surgical-treatment/9886/ In this segment, Dr. Hennon provides an overview of the importance of screening for lung cancer as well as describes recent developments in the diagnosis and surgical management of lung cancer. This activity is part of a series of in-depth discussions with oncology thought leaders at the Roswell Park Cancer Institute in...

Duration:00:15:00

Pathways in Oncology: Tools to Assure Quality Care

5/7/2018
More
CME credits: 0.25 Valid until: 07-05-2019 Claim your CME credit at https://reachmd.com/programs/cme/pathways-in-oncology-tools-to-assure-quality-care/9890/ In this segment, Dr. Edge discusses the benefits of using clinical oncology pathways in practice as well as their optimal use for patients. Also discussed will be how to best select the primary choice for treatment when using clinical oncology pathways. This activity is part of a series of in-depth discussions with oncology thought...

Duration:00:18:30